Sanofi poaches Novartis exec Nathwani as new CMO

New Sanofi ($SNY) CEO Olivier Brandicourt is assembling his top team. The pharma giant announced that Novartis ($NVS) vet Ameet Nathwani has been named EVP and group chief medical officer, earning a seat on the executive committee. Nathwani is taking the place of Paul Chew, who's retiring later in the year. Sanofi has been setting the stage for a reorganization. Release

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

U.K.-based alpha-synuclein biotech Wren will partner with Japanese pharma Eisai to seek out new ways of targeting neuro disorders.

As Moderna continues to drip-feed the latest data from its late-stage COVID-19 vaccine effort, it has updated the shot’s efficacy figure.

Two research teams have discovered drug combinations that may make it possible to translate CAR-T cell therapies to solid tumors.